7-methyljuglone has been researched along with isodiospyrin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chung, TT; Collin, F; Greive, SJ; Karkare, S; Lall, N; Maxwell, A; McKay, AR; Meyer, JJ; Mitchenall, LA | 1 |
Chaudhari, K; Jain, P; Patel, HM; Surana, S | 1 |
Lacey, E; Piggott, MJ; Pullella, GA; Vuong, D | 1 |
1 review(s) available for 7-methyljuglone and isodiospyrin
Article | Year |
---|---|
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
Topics: Antitubercular Agents; Clinical Trials as Topic; DNA Gyrase; Drug Discovery; Humans; Mycobacterium tuberculosis; Topoisomerase II Inhibitors | 2016 |
2 other study(ies) available for 7-methyljuglone and isodiospyrin
Article | Year |
---|---|
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Binding Sites; Catalytic Domain; DNA; DNA Gyrase; Escherichia coli; Humans; Inhibitory Concentration 50; Mass Spectrometry; Models, Chemical; Mycobacterium tuberculosis; Naphthoquinones; Protein Binding; Protein Structure, Tertiary; Staphylococcus aureus; Surface Plasmon Resonance; Tuberculosis | 2013 |
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
Topics: Antineoplastic Agents; Antitubercular Agents; Isomerism; Naphthoquinones | 2020 |